LINC00346 has been documented to be overexpressed in non-small cell lung cancer, bladder cancer, and pancreatic cancer and serves as a positive transcriptional regulator of c-Myc, but its role in glioma has not been reported (32, 33). This evidence concerns the gene MYC and urinary bladder cancer.